JMERC
Owner
Janbazan Medical and Engineering Research Center (JMERC) is the owner of IJWPH.
0.4
Cite Score
SJR: 0.114 / SNIP: 0.090
Volume 15, Issue 3 (2023)
Iran J War Public Health 2023, 15(3): 305-310 |
Back to browse issues page
Article Type:
Subject:
History
Received: 2023/05/2 | Accepted: 2023/09/18 | Published: 2023/09/23
Received: 2023/05/2 | Accepted: 2023/09/18 | Published: 2023/09/23
How to cite this article
AbdulAemah M, Hussein G, Hussein N. Association of Insulin-Like Growth Factor-1 Gene Single Nucleotide Polymorphism rs10860860 with Type 2 Diabetes. Iran J War Public Health 2023; 15 (3) :305-310
URL: http://ijwph.ir/article-1-1329-en.html
URL: http://ijwph.ir/article-1-1329-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
1- Department of Clinical Laboratory Sciences, College of Pharmacy, Al-Mustaqbal University, Hillah, Iraq
2- Department of Clinical Laboratory Sciences, College of Pharmacy, AL-Zahraa University for Women, Karbala, Iraq
3- Department of Pharmacy, Al-Manara College for Medical Sciences, Amarah, Iraq
2- Department of Clinical Laboratory Sciences, College of Pharmacy, AL-Zahraa University for Women, Karbala, Iraq
3- Department of Pharmacy, Al-Manara College for Medical Sciences, Amarah, Iraq
Abstract (983 Views)
Aims: One extremely important public health challenge worldwide is diabetes mellitus. Type 2 diabetes mellitus is a rising concern around the globe. Early revealing of Type 2 diabetes mellitus is very significant in that morbidity associated with the condition can be decreased. Studies have proposed that insulin-like growth factor-1 has roles similar to that of insulin. The existing study was implemented to reveal the alliance of single nucleotide polymorphism rs10860860 of the IGF-1 gene with Type 2 diabetes mellitus.
Materials & Methods: This case-control study was conducted in Merjan Hospital in Babylon Province, Iraq, in 2022. The available random sampling method selected two groups of healthy individuals (n=50 as control) and Type 2 diabetes mellitus patients (n=158 as study). The serum levels of glucose and zinc were determined by spectrophotometric method. The serum IGF-1 level was estimated using the sandwich ELISA technique. The students’ T and Chi-square tests were used to assess data in SPSS 21 software.
Findings: The different levels of glucose, zinc, and IGF-1 were significant between the two groups. Genotyping frequencies of the IGF-1 gene deviated from Hardy Weinberg equilibrium in the control group (χ2=9.158; p=0.002) while were consistent in the study group (χ 2=2.482; p=0.115). The AT genotype was associated with lower odds of Type 2 diabetes mellitus than those of the wild genotype AA.
Conclusion: The AT genotype of IGF-1 gene SNP rs10860860 negatively associates with Type 2 Diabetes Mellitus.
Materials & Methods: This case-control study was conducted in Merjan Hospital in Babylon Province, Iraq, in 2022. The available random sampling method selected two groups of healthy individuals (n=50 as control) and Type 2 diabetes mellitus patients (n=158 as study). The serum levels of glucose and zinc were determined by spectrophotometric method. The serum IGF-1 level was estimated using the sandwich ELISA technique. The students’ T and Chi-square tests were used to assess data in SPSS 21 software.
Findings: The different levels of glucose, zinc, and IGF-1 were significant between the two groups. Genotyping frequencies of the IGF-1 gene deviated from Hardy Weinberg equilibrium in the control group (χ2=9.158; p=0.002) while were consistent in the study group (χ 2=2.482; p=0.115). The AT genotype was associated with lower odds of Type 2 diabetes mellitus than those of the wild genotype AA.
Conclusion: The AT genotype of IGF-1 gene SNP rs10860860 negatively associates with Type 2 Diabetes Mellitus.
Keywords:
References
1. Li XQ, Zheng X, Chen M, Zhao MH. Characteristics of diabetic nephropathy patients without diabetic retinopathy: A retrospective observational study. Med. 2017;96(18):e6805. [Link] [DOI:10.1097/MD.0000000000006805]
2. Ali Khan I, Poornima S, Jahan P, Rao P, Hasan Q. Type 2 Diabetes Mellitus and the Association of Candidate Genes in Asian Indian Population from Hyderabad, India. J Clin Diagn Res. 2015;9(11):GC01-GC05. [Link] [DOI:10.7860/JCDR/2015/14471.6855]
3. Idowu AA, Ajose AO, Adedeji AT, Adegoke AO, Jimoh KA. Microalbuminuria, other markers of nephropathy and biochemical derangements in type 2 diabetes mellitus: Relationships and determinants. Ghana Med J. 2017;51(2):56-63. [Link]
4. Liu H, Wang X, Gao H, Yang C, Xie C. Physiological and pathological characteristics of vascular endothelial injury in diabetes and the regulatory mechanism of autophagy. Fron Endocrinol. 2023;14:1191426 [Link] [DOI:10.3389/fendo.2023.1191426]
5. Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018;34(5):575-84. [Link] [DOI:10.1016/j.cjca.2017.12.005]
6. Ji L, Tian H, Webster KA, Li W. Neurovascular regulation in diabetic retinopathy and emerging therapies. Cell Mol Life Sci CMLS. 2021;78(16):5977-85. [Link] [DOI:10.1007/s00018-021-03893-9]
7. Hsu TH, Ning Y, Gwo JC. AFLP-SSCP: A useful AFLP-based method for informative SNPs discovery in non-model organisms. Adv Biol Chem. 2014;4(6):50291 [Link] [DOI:10.4236/abc.2014.46042]
8. Unnikrishnan R, Anjana RM, Mohan V. Diabetes mellitus and its complications in India. Nat Rev Endocrinol. 2016;12(6):357-70. [Link] [DOI:10.1038/nrendo.2016.53]
9. Hasan Ahmad SA, Ansari SA, Mensah-Brown EPK, Emerald BS. The role of DNA methylation in the pathogenesis of type 2 diabetes mellitus. Clin Epigenetics. 2020;12(104) [Link] [DOI:10.1186/s13148-020-00896-4]
10. Laron Z. Insulin-like growth factor 1 (IGF-1): a growth hormone. Mol Pathol. 2001;54(5):311-16. [Link] [DOI:10.1136/mp.54.5.311]
11. Varewijck A, Janssen J. Insulin and its analogues and their affinities for the IGF1 receptor. Endocr Relat Cancer. 2012;19(5):63-75. [Link] [DOI:10.1530/ERC-12-0026]
12. Zhao T, Huang Q, Su Y, Sun W, Huang Q, Wei W. Zinc and its regulators in pancreas. Inflammopharmacology. 2019;27(3):453-64. [Link] [DOI:10.1007/s10787-019-00573-w]
13. Galicia-Galicia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Scie. 2020;21(17):6275. [Link] [DOI:10.3390/ijms21176275]
14. Boland BB, Rhodes CJ, Grimsby JS. The dynamic plasticity of insulin production in beta-cells. Mol Metab. 2017;6(9):958-973. [Link] [DOI:10.1016/j.molmet.2017.04.010]
15. Rorsman P, Ashcroft FM. Pancreatic beta-cell electrical activity and insulin secretion: of mice and men. Physiol Rev. 2018;98(1):117-214. [Link] [DOI:10.1152/physrev.00008.2017]
16. Fernandez-Cao J, Warthon-Medina M, Moran VH, Arija V, Dpepking C, Majem LS, et al. Zinc intake and status and risk of type 2 diabetes mellitus: a systematic review and meta-analysis. Nutrients. 2019;11(5):1027. [Link] [DOI:10.3390/nu11051027]
17. Shahbaz S, Katti C, Khan M, Pawar K. Evaluation of salivary total protein in insulin dependent diabetes mellitus (IDDM) patients. Int J Cur Res Rev. 2017;9(23). [Link]
18. Blonde L, Aschner P, Bailey C, Ji L, Leiter LA, Matthaei S. Gaps and barriers in the control of blood glucose in people with type 2 diabetes. Diab Vasc Dis Res. 2017;14(3):172-83. [Link] [DOI:10.1177/1479164116679775]
19. Fukasawa H, Niwa H, Ishibuchi K, Kaneko M, Iwakura T, Yasuda H. The impact of serum zinc levels on abdominal fat mass in hemodialysis patients. Nutrients. 2020;12(3):656. [Link] [DOI:10.3390/nu12030656]
20. Saber LM, Youseef AM, Abdellatif MS, Abdel Wahhab KG. Assessment of some major minerals and trace elements levels in female patients with type II diabetes mellitus and their correlation with glycated hemoglobin. Middle East J Appl Sci. 2014;4(2):345-56. [Link]
21. Hussein M, Fathy A, Elkareem RA, Marzouk S, Shawki Kamal Y. Zinc deficiency correlates with severity of diabetic polyneuropathy. Brain Behav. 2021;11(10);e2349. [Link] [DOI:10.1002/brb3.2349]
22. Farooq DM, Alamri AF, Alwhahabi BK, Metwally AM, Kareem KA. The status of zinc in type 2 diabetic patients and its association with glycemic control. J Family Community Med. 2020;27(1):29-36. [Link] [DOI:10.4103/jfcm.JFCM_113_19]
23. Masood N, Baloch GH, Ghori RA, Memon IA, Memon MA, Memon MS. Serum zinc and magnesium in type-2 diabetic patients. J Coll Physicians Surg Pak. 2009;19(8):483-6. [Link]
24. Adriani M, Wirjatmadi B. The effect of adding zinc to vitamin A on IGF-1, bone age and linear growth in stunted children. J Trace Elem Med Biol. 2014;28(4):431-5. [Link] [DOI:10.1016/j.jtemb.2014.08.007]
25. Jayawardena R, Ranasingha P, Galappatthy P, Malkanthi R, Constantine GR, Katulanda P. Effects of zinc supplementation on diabetes mellitus: a systematic review and meta-analysis. Diabetol Metab Syndr. 2012;4(13). [Link] [DOI:10.1186/1758-5996-4-13]
26. Rocha EDM, Brito NJN, Dantas MMG, Silva AA, Almedia MG, Brandao-Neto J. Effect of zinc supplementation on GH, IGF1, IGFBP3, OCN, and ALP in non-zinc-deficient children. J Am Coll Nutr. 2015;34(4):290-9. [Link] [DOI:10.1080/07315724.2014.929511]
27. Ren W, Zhao C, Wang Y, Fang Y, Huang Z, Chen W, et al. Ramipril can alleviate the accumulation of renal mesangial matrix in rats with diabetic nephropathy by inhibiting insulin-like growth factor-1. Acta Cir Bras. 2019;34(1):e20190010000007 [Link] [DOI:10.1590/s0102-865020190010000007]
28. Maximus PS. Insulin like growth factor 1 is linked to higher cardiovascular risk score in adults with type 2 diabetes mellitus and chronic kidney disease. Diabetes Metabo Syndr. 2019;13(4):2613-8. [Link] [DOI:10.1016/j.dsx.2019.07.008]
29. Mancuso E, Mannino G, Di Fatta C, Fuoco A, Spiga R, Andreozzi F, et al. Insulin-like growth factor-1 is a negative modulator of glucagon secretion. Oncotarget. 2017;8(31):51719-32. [Link] [DOI:10.18632/oncotarget.18514]
30. Teppala S, Shankar A. Association between serum IGF-1 and diabetes among U.S. adults. Diabetes Care. 2010;33(10):2257-9. [Link] [DOI:10.2337/dc10-0770]
31. Sandhu MS, Dunger DB, Giovannucci EL. Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst. 2001;94(13):972-80. [Link] [DOI:10.1093/jnci/94.13.972]
32. Dorgan D, Schulze MB, Boeing H, Pischon T. Insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in relation to the risk of type 2 diabetes mellitus: results from the EPIC-Potsdam Study. Am J Epidemiol. 2016;183(6):553-60. [Link] [DOI:10.1093/aje/kwv188]
33. Janssen J. IGF-I and the endocrinology of aging. Curr Opin Endocr. 2019;5:1-6. [Link] [DOI:10.1016/j.coemr.2018.11.001]
34. Dorup I, Flyvbjerg A, Everts ME, Clausen T. Role of insulin-like growth factor-1 and growth hormone in growth inhibition induced by magnesium and zinc deficiencies. Br J Nutr. 1991;66(3):505-21. [Link] [DOI:10.1079/BJN19910051]
35. Rietveld I. An insulin-like growth factor-I gene polymorphism modifies the risk of microalbuminuria in subjects with abnormal glucose tolerance. Eur J Endocrinol. 2006;154(5):715-21. [Link] [DOI:10.1530/eje.1.02144]
36. Elias Z. Impact of Hardy Weinberg equilibrium deviation on allele-based risk effect of genetic association studies and meta-analyses. Eur J Epidemiol. 2010;25(8):553-60. [Link] [DOI:10.1007/s10654-010-9467-z]
37. Hegazi MAM, Seleem A, El-Adawy EH, Elhussini MEA. Association of IGF-I gene polymorphism with diabetic nephropathy in Egyptians with type 2 diabetes. Egypt J Intern Med. 2018;30(4):191-6. [Link] [DOI:10.4103/ejim.ejim_48_18]